Immune endotypes and treatment response in psoriatic arthritis

Key Points

• Response to treatment is significantly influenced by identified immune endotypes.
• The study found a notable 35% variation in treatment outcomes linked to immune factors.
• Analysis of biomarkers associated with cytokines reveals potential therapeutic targets.
• Understanding immune endotypes may enable more personalized treatment strategies for psoriatic arthritis.